Evidence map›Paper›PMID 30023723›Full record

ArticleACS omega2017

Modification of Honeybee Silk by the Addition of Antimicrobial Agents.

Holly E Trueman, Alagacone Sriskantha, Yue Qu, Trevor D Rapson, Tara D Sutherland

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Resolving the structure and assembly of the honeybee silk heterotetrameric coiled coil.Protein science : a publication of the Protein Society · 2025
    Article
  2. The future of recombinant host defense peptides.Microbial cell factories · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Holly E TruemanCSIRO, GPO Box 1700, Canberra, ACT 2601, Australia.
Alagacone SriskanthaCSIRO, GPO Box 1700, Canberra, ACT 2601, Australia.
Yue QuDepartment of Infectious Diseases, The Alfred Hospital, 4/55 Commercial Rd., Melbourne 3004 Victoria, Australia.
Trevor D RapsonCSIRO, GPO Box 1700, Canberra, ACT 2601, Australia.
Tara D SutherlandCSIRO, GPO Box 1700, Canberra, ACT 2601, Australia.
Commonwealth Scientific and Industrial Research Organisation · AUThe Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Honeybee silk proteins can be produced at high levels in recombinant systems, fabricated into materials, and are tolerant of amino acid modifications: properties that make them exciting templates for designing new functional materials. Here, we explore the properties of materials either made from silk-antimicrobial peptide (AMP) fusion proteins or silk containing entrapped AMPs or silver nanoparticles. Inclusion of AMP within the silk protein sequence did not affect our ability to express the proteins or process them into films. When AMP-silk proteins and

Identifiers

PMID30023723
PMCPMC6044942
OpenAlexW2743367205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.